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The association between naevi and melanoma in
populations with different levels of sun exposure: a joint
case-control study of melanoma in the UK and Australia
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'Imperial Cancer Research Fund Skin Tumour Laboratory, London, UK; 2National Centre in HIV Epidemiology & Clinical Research, Sydney, Australia;
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and Tropical Medicine, Keppel Street, London, UK; 5Dermatology Department, St James University Hospital, Leeds, UK; 6Melanoma Unit, Royal Prince Alfred
Hospital, Sydney, Australia; 7Melanoma Unit, Wallsend Hospital, Newcastle, NSW, Australia.
Summary Two case-control studies were set up to investigate the relationship between melanocytic naevi and risk of melanoma and to
compare the naevus phenotype in two countries exposed to greatly different levels of sun exposure and different melanoma rates. In England
117 melanoma cases and 163 controls were recruited from the North-East Thames Region and 183 melanoma cases and 162 controls from
New South Wales, Australia. Each subject underwent a whole-body naevus count performed by the same examiner in each country. Relative
risks associated with melanocytic naevi in each country were calculated with comparison of naevus data in controls between Australia and
England. Atypical naevi were strong risk factors for melanoma in both countries: the odds ratio (OR) for three or more atypical naevi was 4.6
(95% Cl 2.0-10.7) in Australia compared with 51.7 (95% Cl 6.5-408.4) in England. Common naevi were also significant risk factors in
Australia and England with similar odds ratios in the two countries. Prevalence of atypical naevi was greater in Australian controls than in
English controls: OR 9.7 (95% Cl 1.2-81.7) for three or more atypical naevi in Australia compared with England. For young age groups, the
median number of common naevi was greater in Australia than in the UK, whereas for older individuals this difference in naevi number
between the two countries disappeared. The prevalence of naevi on non-sun-exposed sites in controls was not significantly different between
the two countries. The atypical mole syndrome (AMS) phenotype was more prevalent in Australian controls (6%) than in English controls
(2%). The results of this study support the role of sun exposure in the induction of atypical naevi in adults. There was a trend towards stronger
risk factors associated with atypical naevi in England compared with Australia. The atypical mole syndrome, usually associated with a genetic
susceptibility to melanoma, was more common in Australia than in England, suggesting genetic environmental interactions with the possibility
of phenocopies induced by sunlight.
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Australia has the highest incidence of melanoma in the world, with
the highest regional incidence in the State of Queensland
(MacLennan et al, 1992). Atypical naevi and large numbers of
common naevi are the most powerful predictors for an increased
risk of melanoma, with significant relative risks shown in
Australia (Holman and Armstrong, 1984a) as well as Sweden,
Denmark, UK, Canada, USA and France (Holly et al, 1987;
Osterlind et al, 1988; Augustsson et al, 1991; Gallagher et al,
1990; Grob et al, 1990; Bataille et al, 1996). The incidence of
melanoma in Australia is thought to be attributable to high levels
of sun exposure, but it is not entirely clear to what extent exposure
to ultraviolet radiation affects the development of common and
atypical naevi. Kelly et al (1994) reported that children from
Queensland, Australia, had higher numbers of naevi than children
from Victoria (the latter being further away from the equator), and
other studies in children have also suggested that sun exposure
early in life induces naevi (Holman and Armstrong, 1984b;
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Fritschi et al, 1994; Harrison et al, 1994). In adults, there have
been no formal studies looking at the difference in naevus pheno-
type in countries with different exposure patterns. Based on
naevus count studies, there is no evidence of a relationship
between mean numbers of naevi per individual and melanoma
incidence in different countries: naevus-counting studies in
healthy individuals in Australia (Nicholls, 1973), New Zealand
(Cooke et al, 1985) and the USA have not shown major differ-
ences in mean naevus count from those carried out in the UK
(MacKie et al, 1985) and Switzerland (Sigg and Peloni 1989).
However, these studies have involved different examiners and
different naevus-counting protocols, and the results are difficult to
compare. Similarly, relative risks for melanoma associated with
naevi have differed between studies, but no clear association has
been found between the magnitude of the relative risks in one area
and melanoma incidence there.
The atypical mole syndrome phenotype (AMS) has been shown
to be a strong predictor of increased melanoma risk in population-
based case-control studies in the UK and elsewhere (MacKie et al,
1995; Holly et al, 1987; Bataille et al, 1996). This phenotype is
known to be expressed in individuals with a genetic susceptibility
to melanoma (Greene et al, 1985; Newton Bishop et al 1994).
However, it is possible that high levels of sun exposure influence
its expression. The UK and Australia share a common genetic pool
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Table 1 Age and sex distribution of subjects examined by VB only in
Australia and the UK
Australian Australian English English
cases controls cases controls
Number of 163 162 117 183
subjects
Percent of males 63 36 37 40
Mean age 50 49 49 46
(years)
but very different UVR environment. No studies, as yet, have
compared the prevalence of common and atypical naevi in
melanoma cases and controls between countries with different sun
exposure. A comparison study was therefore conducted by
carrying out two case-control studies of melanoma in Australia
and England using the same mole-counting protocol and examiner
in both studies.
MATERIAL AND METHODS
Case-control studies were carried out in the North-East Thames
region of England and in New South Wales, Australia. Details of
the methods used for the respective studies have been published
elsewhere (Bataille et al, 1996; Grulich et al, 1996). The UK study
included cases diagnosed between August 1989 and July 1993.
The Australian study recruited cases at the Sydney and Newcastle
Melanoma Units between November 1992 and May 1993. For
both studies, all cases were diagnosed with primary melanoma
(melanoma in situ and lentigo malignant melanoma included) after
November 1989, and were residents in the regions. In both studies,
controls were recruited from hospitals and general practices within
the region. Patients and their spouses were eligible provided they
were not seen for skin or chronic diseases. All cases and controls
were aged between 16 and 80 years of age. The naevus count
protocol was identical for both studies, but the questionnaire was
slightly altered to accommodate for differences in sun exposure
between the two countries. All subjects in both countries were
white and, for the Australian study, country of ancestral origin was
determined by the grandparents' countries of birth. In England,
426 melanoma cases and 416 controls were recruited, whereas in
Australia the study included 259 cases and 281 controls. One
dermatologist (VB) was involved in both studies and examined
117 cases and 163 controls in England and 183 cases and 162
controls in Australia. These patients, examined by the same
dermatologist, form the subject of the present paper. Ethics
Committee approval was obtained at the Royal London Hospital,
London, for the UK study and Royal Prince Alfred Hospital,
Sydney, for the Australian study.
For the English and Australian studies, hair and eye colour were
recorded. All cutaneous naevi greater than or equal to 2 mm in
diameter were counted except on genitalia, female breast and
posterior scalp. The naevi were also recorded according to size
(2-4 mm, 5-9 mm, 2 10 mm) and clinical features (irregular
border, irregular pigment) for each of 17 body areas. Clinically
atypical, congenital and blue naevi were recorded separately. An
atypical naevus was defined as a melanocytic lesion of 5 mm in
diameter or above with irregular pigmentation and/or an irregular
or hazy border. The AMS phenotype was defined using a scoring
system for the AMS phenotype (Newton et al, 1994) and was based
on five clinical features: (a) 100 or more common naevi > 2 mm in
diameter; (b) two or more atypical naevi; (c) one or more naevi on
the buttock and/or two or more naevi on the dorsum of the feet; (d)
one or more naevi on the anterior scalp; and (e) one or more
pigmented lesion of the iris. Individuals were considered affected
if they scored three or more out of a maximum score of five.
Comparisons between the variables were based on a retrospec-
tively stratified analysis using unconditional logistic regression
(Breslow and Day, 1980). To control for potential confounding
factors, multiple regression models were fitted. The regression
equations included terms for age in decades, sex and hair colour.
Inclusion in the model of other variables such as eye colour and
ethnicity did not substantially modify any of the estimates and are
therefore omitted from the analyses presented. The dependent vari-
able was either case-control status or Australia-UK status. Some
analyses were limited to controls only. Unless otherwise stated,
odds ratios presented in the text were based on a comparison
between the presence and the absence of a trait. For instance, when
an odds ratio for two or more atypical naevi is quoted, the compar-
ison group is fewer than 2. Ninety-five per cent confidence inter-
vals and significance levels were based on the asymptotic
approximation of the estimated logarithm of the odds ratio and its
standard error. Chi-squared tests for trend were based on the likeli-
hood ratio and one degree of freedom. Each trend test was based on
linear scoring of the groups shown in Tables 1-4 and the odds
ratios represent those associated with an increase in the variable of
interest by one level. Thus, for an increase of three levels, one
should cube the odds ratios. The attributable proportion of the
disease in the population due to exposure was calculated from esti-
mated relative risks and the proportion of cases exposed. The expo-
sure distribution in cases was used because the age and sex
distribution of controls were approximately frequency matched to
that of cases, whereas the cases are representative of all cases.
Confidence intervals for the attributable proportion calculated in
this way were based on the formula for the variance of the loga-
rithm of the attributable proportion given by Greenland (1987).
The curves for Figures 1 and 2 were produced using median
regression on a cubic spline in age. The estimation is based on least
absolute deviations (as opposed to least squares which is mean
based and would have been unduly influenced by individuals with
an exceedingly large number of naevi) and was performed using
the 'qreg' command in STATA (Stata Corp, TX, USA).
RESULTS
Age, sex, ethnicity and hair colour
The mean age of the melanoma cases was similar in the English
and Australian studies (Table 1). There were more women than
men among the melanoma cases in the UK (female-male ratio
1.5), whereas in Australia there were more male cases than female
cases (female-male ratio of 0.7). The male-female ratios are
representative of a genuine difference in the male to female ratios
in all incident melanoma cases between the respective countries.
All analyses are adjusted for age and sex. In the Australian study,
95% of the cases and 92% of the controls were of northern
European origin, with 75% of the cases and 70% of the controls of
British origin. The distribution of hair colour in UK and Australian
cases was similar between the two countries: 20% of the
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Table 2 Sites of melanoma in Australia and the UK
Australia England
Number Number Number Number
of men of women of men of women
(%) (%) (%) (%)
Head and neck 32 (21) 8 (8) 32 (21) 29 (12)
Back 62 (40) 21 (20) 59 (37) 29 (12)
Chest and abdomen 12 (8) 5 (4) 23 (14) 14 (6)
Arms 15 (10) 28 (27) 16 (10) 47 (20)
Legs 21 (14) 35 (34) 26 (17) 110 (49)
Not specified 10 (6) 9 (8) 2 (1) 3 (1)
Total 152 (100) 106 (100) 159 (100) 242 (100)
Australian controls had blond hair compared with 22% in the UK.
For red hair, the prevalence was 7% and 12% for the Australian
and UK controls respectively. The distribution of eye colour and
skin type was similar between the two countries (data not shown).
Histological subtype, site and thickness of melanoma
Table 2 shows the sites of melanomas in men and women in
Australian and English cases (all cases seen in each country shown
in this table and not restricted to those examined by VB alone). No
significant differences in the site of melanomas, according to sex,
was found between the two countries. The distribution of histolog-
ical subtypes was similar in the two countries, with a majority of
melanomas being of superficial spreading melanoma (SSM) type:
61% SSM of the 258 cases in Australia compared with 60% SSM
of the 426 cases in the UK. There were no significant differences
in the percentage of other histological subtypes between the two
countries. The mean thickness of the melanomas for the Australian
cases was 1.5 mm compared with 1.4 mm for the English cases.
Comparison of the naevus prevalence between
Australia and England
Table 3 shows the prevalence of common and atypical naevi, naevi
on relatively sun protected sites and the AMS scores in Australian
controls vs English controls. The odds ratios express the difference
between the two countries and are adjusted as shown. Inclusion of
cases or controls of British origin only from the Australian study,
made no significant differences to the results (estimates changed
by no more than 2%).
Atypical naevi were more common in Australian controls than
in English controls: the odds ratio for the difference between the
two countries for three or more atypical naevi was 9.7 (1.2-81.7).
The numbers of common and atypical naevi were found to
decrease with age in both countries. In England, in controls aged
below 45 years, the median number of naevi was 22 (95% CI
16-31) compared with 10 (95% CI 7-14) in controls aged 45 years
or over (P<0.0001), whereas in Australia, the median number of
naevi for the same age groups was 39 (95% CI 26-57) and 7 (95%
CI 5-11) respectively (P<0.0001). The median number of naevi in
Australia and the UK as a function of age for cases and controls are
shown in Figures 1 and 2 respectively. Atypical naevi were signif-
icantly associated with fair hair in both countries (x2=5.7; P=0.02
for the association in Australia and X2=10.91; P=0.001 for the
association in England). The prevalence of naevi on the dorsum of
Table 3 Numbers of naevi in Australian and UK controls and odds ratio for
frequency of each charactenstic in Australian controls compared with UK
controls
Australian UK OR1
controls controls
(n = 162) (n = 163)
Numbers of common naevi
0-4 42(26) 33(20) 1.0
5-9 24 (15) 24 (15) 0.9 (0.4-2.0)
10-24 39 (24) 52 (32) 0.7 (0.4-1.5)
25-49 22 (14) 30 (18) 0.7 (0.3-1.7)
50-99 21 (13) 18(11) 1.2(0.5-3.1)
. 100 14 (9) 6 (4) 2.7 (0.9-8.4)
Chi-square test for trend 1.4 P = 0.2
Numbers of atypical naevi
0 136 (85) 149 (91) 1.0
1 13 (8) 8 (5) 2.2 (0.8-5.6)
2 4(2) 5(3) 1.1 (0.3-4.3)
.3 8(5) 1 (1) 9.7(1.2-81.7)
Chi-square test for trend 5.7 P = 0.02
Numbers of naevi on
the dorsum of the feet
0 139 (85) 136 (83) 1.0
1 12 (7) 15 (9) 0.8 (0.3-1.8)
2 7 (4) 8 (5) 1.0 (0.3-3.0)
23 4 (2) 8 (2) 1.1 (0.2-4.5)
Chi-square test for trend 0.01 P = 0.9
Numbers of naevi on
the buttocks
0 131 (81) 142 (87) 1.0
1 9 (6) 13 (8) 0.9 (0.3-2.2)
2 8 (5) 6 (4) 1.9 (0.6-6.2)
.3 13 (8) 2 (1) 8.2 (1.7-38.9)"
Chi-square test 7.5 P = 0.007
AMS score
0 112 (69) 108 (66) 1.0
1 30 (19) 45 (28) 0.7 (0.4-1.2)
2 10 (6) 7 (4) 1.7 (0.6-4.8)
23 10 (6) 3(2) 4.1 (1.1-15.6)*
Chi-square test 2.1 P=0.1
OR1 for the differences in prevalence in controls between the two countries,
adjusted for sex, age and hair colour. *P < 0.05. **P < 0.001.
the feet was similar between the two countries. The presence of
three or more naevi on the buttocks was more prevalent in
Australia than in England. Naevi on the scalp were found more
commonly in Australian controls than English controls, with an
odds ratio of 1.8 (P= 0.01) (not shown in Table 3).
Twenty four per cent of the Australian cases were found to have
the AMS phenotype compared with 16% of the English cases (OR
= 1.7 (95% CI 1.1-2.7) for Australian cases vs English cases). Six
per cent of the Australian controls were found to have the AMS
phenotype compared with 2% of the English controls [4.1 (95% CI
1.1-15.6)].
Risk of melanoma associated with naevi in Australia
and England
Table 4 shows relative risks of melanoma in Australia and in
England in relation to numbers of common and atypical naevi,
British Journal of Cancer (1998) 77(3), 505-5100 Cancer Research Campaign 1998
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Figure 1 Median number of naevi in Australia and the UK according to age
in cases
naevi on the dorsum of the feet and buttocks, and the AMS score.
Atypical naevi were a weaker risk factor for melanoma in
Australia than in England, although the difference between the
countries was not statistically significant. For naevi on relatively
sun-protected sites (such as the buttocks and dorsum of the feet),
the magnitudes of the odds ratios were similar in the two countries
(Table 4). The presence of one or more naevi on the anterior scalp
yielded odds ratios of 2.2 (95% CI 1.3-3.8) in Australia and 2.4
(95% CI 1.4-4.2) in England. Iris naevi were significantly associ-
ated with melanoma in both countries: OR of 2.0 (95% CI 1.2-3.2)
in Australia and 1.7 (95% CI 1.2-2.6) in England for the presence
of one or more iris naevi. The presence of the AMS phenotype
(score of three or more on the scoring system) gave an odds ratio
of 23.2 (6.1-87.7) in England compared with 9.4 (4.1-21.7) in
Australia. In England, the mean age of the AMS cases was 46
(compared with 52 in non-AMS cases; P=0.003), whereas in
Australia the mean age ofAMS cases was 44 [compared with 53 in
the non-AMS cases (P<0.0001)]. There was no association
between the presence of the AMS phenotype and melanoma thick-
ness in either country. The AMS phenotype was more common in
male than in female cases in each country, but this only reached
significance in England: 23% of the male cases in England scored
3 or more on our scoring system compared with 11% of the female
cases (P = 0.001) and the comparable figures for Australia were
26% and 20% for men and women respectively (P=0.2).
Nineteen per cent of the melanomas in Australia were 'attribut-
able' to the presence of the AMS phenotype compared with 16%
of the melanomas in England. These attributable proportions were
affected by age, 25% (95% CI 11-56%) of the melanomas below
the age of 50 in Australia were attributable to the AMS phenotype
125 -
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Figure 2 Median number of naevi in Australia and the UK according to age
in controls
compared with 16% (95% CI 3-44%) of the melanomas for this
age group in England, whereas at ages 50 and above the attribut-
able proportions were 13% (95% CI 4-55%) and 12% (95% CI
3-44%) respectively.
DISCUSSION
In several case-control studies of melanoma in Australia (Green et
al, 1986; Armstrong and English, 1988); Europe (Swerdlow et al,
1986; Osterlind et al, 1988; Grob et al 1990; Augustsson et al,
1991) and North America (Gallagher et al 1990, Holly et al 1987),
large numbers of common and atypical naevi have been the
strongest risk factors found for this tumour. Naevus count studies
have shown that UVR exposure probably influences the expres-
sion of the naevus phenotype in children (Fritschi et al, 1994;
Harrison et al 1994; Kelly et al, 1994), but this has not been
formally shown in adults. The importance of genetic factors in the
induction of naevi has been demonstrated in studies on familial
melanoma and the AMS with an autosomal dominant pattern of
inheritance (Cannon-Albright et al, 1992; McGeogh et al, 1994;
Newton et al, 1994). The AMS phenotype was also found to be
strongly predictive of an increased risk in a sporadic melanoma
population in the UK and atypical naevi have been associated with
melanoma risk in many case-control studies (Swerdlow et al,
1986; Holly et al, 1987; Bataille et al, 1996). The present study
investigated possible gene environment interactions in the induc-
tion of naevi by comparing the naevus phenotype between two
populations with different sun exposure patterns but a similar
genetic pool. The same naevus count protocol was used by the
same examiner in both studies, minimizing the problem of
British Journal of Cancer (1998) 77(3), 505-510
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Table 4 Risk of melanoma associated with naevus variables in Australia
and England
OR Australian OR UK study Ratio of OR
study (95% Cl) Australia/
(95% Cl) OR UK
Numbers of common
naevi . 2 mm in
diameter
0-4
5-9
10-24
25-49
50-99
2 100
Odds ratiosa
Chi-square test
Numbers of atypical
naevi
1.0
0.9 (0.3-2.2)
1.5 (0.7-3.3)
4.2 (1.7-10.3)**
4.5 (1.-11.1)*..
1 2.7 (4.9-33.5)***.
1.0
1.1 (0.4-3.1)
1.5 (0.6-3.7)
2.9 (1.0-7.6)*
10.1 (3.8-27.4)*..
16.5 (4.5-60.3)***
1.0
0.8 (0.2-3.2)
1.0 (0.3-3.3)
1.5 (0.4-5.5)
0.4 (0.1-1.7)
0.8 (0.2-3.9)
1.7 (1.4-2.0)*.. 1.9 (1.5-2.3)*.. 0.9 (0.7-1.2)
0 1.0
1 1.3 (0.6-2.9)
2 3.9 (1.1-13.6)*
> 3 4.6 (2.0-10.7)**
Odds ratiosa 1.7 (1.3-2.2)***
Numbers of naevi on the
dorsum of the feet
0
1
.2
Odds ratiosa
Numbers of naevi on
the buttocks
0
1
2
.3
Odds ratiosa
AMS score
0
1
2
.3
Odds ratiosa
1.0
3.4(1.5-7.5)-
1.0
3.0 (1.1-8.2)
1.4 (0.4-5.9)
51.7 (6.5-408.4)***
2.6 (1.8-3.8)***
1.0
2.8 (1.3-6.0)*
4.5 (2.1-9.9)**
1.0
0.4 (0.1-1.6)
2.7 (0.4-17.9)
0.1 (0.0-0.8)
0.7 (0.4-1.0)
1.0
1.2 (0.4-3.6)
0.6 (0.2-1.9)
1.9 (1.3-2.0)** 2.2 (1.5-3.2)*** 0.8 (0.2-1.5)
1.0
2.2 (0.9-5.5)
3.5 (1 .4-90)
3.8 (1.7-8.5)**
1.6 (1.2-21)***
1.0
2.3 (1.3-4.3)**
6.8 (2.8-16.5)***
9.4 (4.1-21.7)***.
1.0
3.0 (1.3-6.7)
3.7 (1.1-12.1)*
14.3 (3.0-69.4)**
2.3 (1.6-3.4)*..
1.0
2.5 (1.4-4.5)**
8.5 (3.1-23.8)***
23.2 (6.1-87.7)***
1.0
0.8 (0.2-2.6)
1.3 (0.3-5.6)
0.3 (0.05-1.8)
0.7 (0.4-1.1)
1.0
0.9 (0.4-2.2)
0.8 (0.2-3.1)
0.4 (0.1-2.0)
2.2 (1.7-2.9)*** 2.8 (2.0-3.9)*** 0.8 (0.5-1.2)
Odds ratios adjusted for age, sex, hair colour for the cases and controls seen
by VB only. aOdds ratio associated with each increasing step of the trend.
*P < 0.05. **P < 0.001.
comparing naevus data between countries. This study concentrates
on the comparison of the naevus phenotype between the UK and
Australia. Comparison of melanoma characteristics between the
two countries was difficult because the studies were not carried out
during the same period and for Australia, did not include incident
cases. For the English study, all the incident cases over a 4-year
period were flagged from pathology reports and 60% took part in
the study. For the Australian study, it would not have been practi-
cably possible to recruit all incident cases of melanoma in a 3-year
period in New South Wales. However, the melanoma cases
included in this study were representative of incident cases in New
South Wales over the 3-year period (I1989-91) and this comparison
has been reported elsewhere (Grulich et al, 1996). Although,
ideally, one would have only compared individuals from a
common genetic pool (i.e. of British origin), for the UK study we
only collected country of birth and did not have details on the
grandparents' country of birth so identification of the non-British
individuals or indeed those of Celtic origin was not possible. As
non-British Caucasians were not excluded from the UK study, it
was appropriate to compare the two countries without excluding
the individuals of non-British origin in Australia. Furthermore,
excluding the Australian subjects of non-British origin made no
significant differences to our results. The male-female ratio in
cases differed between the two countries and this reflected the
male-female ratio for all incident cases in the respective countries.
For controls, the male-female ratio was similar in the UK and in
Australia. For the naevus comparisons, the cases were similar
concerning age, hair or eye colour, types and thickness of
melanoma and the controls were similar concerning age, hair or
eye colour. All of our results have been adjusted for sex and age so
that the difference in sex ratio for melanoma cases between
Australia and England did not affect the comparison.
Atypical naevi prevalence was significantly greater in Australian
than English controls. The number of common naevi was only
slightly and not significantly greater in Australia, implying that
high levels of sun exposure preferentially induces atypical naevi
that may arise de novo or from common naevi. The difference in
the number of common naevi between the two countries is most
apparent for younger age groups, whereas in older individuals the
mean number of common naevi are very similar. As several other
studies suggest that sun exposure can induce naevi in childhood,
this difference in naevi numbers is still evident in early adulthood
and then disappear with age. This could imply that sun exposure is
naevogenic in younger age groups but is also responsible for the
involution of naevi in older subjects, which has been suggested in
earlier studies (Kopf et al, 1978; Armstrong et al, 1986).
The greater prevalence of atypical naevi and the AMS pheno-
type in Australia implies that UVR can induce this phenotype. The
odds ratios for melanoma in relation to common naevi were
similar between the two countries, whereas for atypical naevi and
the AMS phenotype there was evidence of larger odds ratios in
England compared with Australia. This pattern would be expected
if high-risk genetically determined AMS have been diluted in
Australia by the presence of many individuals with 'sun-induced
AMS', which may confer a lower risk of melanoma.
Twenty five per cent of all melanomas below the age of 50 were
statistically attributable to the AMS phenotype in Australia
compared with 16% in England, and the predictive value of the
AMS phenotype decreased with age in both countries. The mean
age of melanoma was in the early fifties in both countries and the
AMS phenotype would be a poor predictor of melanoma in that
older age group. For younger age groups, however, the presence of
two or more atypical naevi or the presence of the AMS phenotype
may be more powerful predictors of risk. Individuals with large
numbers of atypical or common naevi should be especially targeted
for self-examination and reduction of sun exposure in Australia. In
the UK, the incidence of melanoma is much lower and the presence
of the AMS phenotype accounts for a lower proportion of
melanoma, so the public health gain from measures targeted at this
group would be less. However, this phenotype is more predictive of
an increased risk of melanoma in the UK than in Australia.
Screening the UK population for the AMS phenotype is unlikely to
significantly reduce melanoma mortality, but there may be a need
for more public education emphasising the importance of the
naevus phenotype as a risk factor for melanoma in the UK with a
view to encouraging reduction of sun exposure and self-examina-
tion (with self-selected screening) in the high-risk groups.
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This study supports the importance of UVR exposure in the
expression of the naevus phenotype. As for many other cancers,
gene environment interaction plays an important role in melanoma
and the relative contribution of genetic factors and sun exposure in
the causation of melanoma and the expression of the naevus
phenotype needs to be further elucidated. Further advances in
AMS family studies may lead to the discovery of one, or more
likely several, genes responsible for naevus expression. The high
penetrance of the AMS phenotype in melanoma families suggests
that genetic factors are important (Greene et al, 1985; Newton et
al, 1994). Furthermore, a UK study reported high concordance in
naevi number in monozygotic twins compared with dizygotic
twins, but the numbers were small (Easton et al, 1991). Despite
different levels of sun exposure in Australia and the UK, the histo-
logical subtypes and sites of melanomas were very similar
between countries, implying that sun exposure does not greatly
influence part of the biological behaviour of the disease. The pres-
ence of atypical naevi or the AMS phenotype may be a useful
screening tool for melanoma in younger age groups, especially in
Australia. However, follow-up and intervention studies are needed
to determine whether screening for young AMS individuals will
be useful and, furthermore, whether reducing sun exposure in
these high-risk groups will reduce melanoma incidence.
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